Eight officers depart at major caps; Cryo-Cell faces delisting

Eight officers depart at major caps; Cryo-Cell faces delisting

Eight companies filed officer departures on May 8, marking an unusually concentrated wave of executive transitions including Edwards Lifesciences (EW), FedEx (FDX), Baxter International (BAX), ADT Inc. (ADT), Pool Corp. (POOL), Nu Skin Enterprises (NUS), Crescent Capital BDC (CCAP), and Cryo-Cell International (CCLI). Separately, Cryo-Cell disclosed a delisting notice, while smaller-cap Arrive AI (ARAI) flagged for multiple red items including restatement risk and delisting exposure. QVC Inc. entities (QVCDQ, QVCAQ) and La Rosa Holdings (LRHC) each posted dual bankruptcy-risk signals alongside delisting concerns. Fermi Inc. (FRMI) aggregated the highest officer-departure count at seven separate departures. Monitor whether officer exits at large-cap names correlate with broader governance or operational shifts.